| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention concerns administering an urokinase inhibitor representing 4-chlorobenzylsulphonyl-(D)-Seg-Gly-(4-guanidinobenzyl)amide or its pharmaceutically acceptable salt for prevention and/or treatment of amyotrophic lateral sclerosis, a pharmaceutical composition for prevention and/or treatment of amyotrophic lateral sclerosis, administration thereof for treatment and/or prevention of neuropathological and/or neurodegenerative diseases, as well as a method for urokinase activity inhibition. ^ EFFECT: improved clinical effectiveness. ^ 7 cl, 8 dwg, 6 ex |
